Further research is needed to clarify sex-specific mitochondrial mechanisms and develop non-invasive plasma-based biomarkers to target early cognitive dysfunction and slow AD progression.

Studying the possible association between AI and cognitive dysfunction has accelerated over the past 7 years. A pilot study using neuropsychological testing from the Arimidex, Tamoxifen ...